Irbesartan and Hydrochlorothiazide · IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet · Oral · Hikma Pharmaceuticals USA Inc.
NDC 00054-0254-13 · 30 TABLET in 1 BOTTLE · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 27% over the past year, to $0.1405 per unit.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00054-0254-22) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Proficient Rx LP | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | IRBESARTAN 150 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | IRBESARTAN 300 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 22, 2026 |
| Alembic Pharmaceuticals Inc. | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | IRBESARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Hikma Pharmaceuticals USA Inc. | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Hikma Pharmaceuticals USA Inc. | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Proficient Rx LP | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Remedyrepack Inc. | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Solco Healthcare US, LLC | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 300 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Solco Healthcare US, LLC | IRBESARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 150 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Bryant Ranch Prepack | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 19, 2026 |
| Alembic Pharmaceuticals Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Alembic Pharmaceuticals Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Alembic Pharmaceuticals Limited | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Alembic Pharmaceuticals Limited | HYDROCHLOROTHIAZIDE 25 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Alembic Pharmaceuticals Limited | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Hikma Pharmaceuticals USA Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Hikma Pharmaceuticals USA Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Proficient Rx LP | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Remedyrepack Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Solco Healthcare US, LLC | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 150 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Solco Healthcare US, LLC | HYDROCHLOROTHIAZIDE 12.5 mg/1; IRBESARTAN 300 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Irbesartan and Hydrochlorothiazide — NDC 00054-0254-13," retrieved September 3, 2026, https://drugdashboards.com/drug/00054025413.
Free to cite with attribution — see how the data is put together.